Form4insider filings, from the source

SEC Form 4 · accession 0001203311-15-000050

SEATTLE GENETICS INC /WA · SGEN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Eric Dobmeier
Officer — Chief Operating Officer
Period of report
Aug 20, 2015
Accepted (ET)
Aug 25, 2015 · 8:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 20, 2015S8,548$42.0246D74,407D
Common StockAug 24, 2015M4,688$20.52A79,095D
Common StockAug 24, 2015M245$15.46A79,340D
Common StockF2,F3,F4Aug 25, 2015A19,000$0.00A98,340D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Incentive Stock Option (right to buy)F5$15.46Aug 24, 2015M245D—Aug 24, 2021Common Stock2450D
Incentive Stock Option (right to buy)F6$20.52Aug 24, 2015M4,688D—Jun 30, 2021Common Stock4,6880D
Incentive Stock Option (right to buy)F7$39.15Aug 25, 2015A2,554A—Aug 25, 2025Common Stock2,5542,554D
Non-Qualified Stock Option (right to buy)F7$39.15Aug 25, 2015A44,946A—Aug 25, 2025Common Stock44,94644,946D

Explanation of responses